Cita APA

Kapitza, C., Nosek, L., Jensen, L., Hartvig, H., Jensen, C. B., & Flint, A. (2015). Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel. J Clin Pharmacol.

Chicago Style Citation

Kapitza, Christoph, Leszek Nosek, Lene Jensen, Helle Hartvig, Christine B. Jensen, i Anne Flint. "Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel." J Clin Pharmacol 2015.

Cita MLA

Kapitza, Christoph, et al. "Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel." J Clin Pharmacol 2015.